Computed tomography-based prediction model for identifying patients with high probability of non-muscle-invasive bladder cancer

被引:4
|
作者
Kang, Kyung A. [1 ]
Kim, Min Je [1 ]
Kwon, Ghee Young [2 ]
Kim, Chan Kyo [1 ]
Park, Sung Yoon [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, 81 Irwon Ro, Seoul 06351, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea
关键词
Bladder; Cancer; Computed tomography; Magnetic resonance imaging; CT UROGRAPHY; DIAGNOSTIC PERFORMANCE; ENHANCEMENT; CARCINOMA; STALK;
D O I
10.1007/s00261-023-04069-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To investigate computed tomography (CT)-based prediction model for identifying patients with high probability of non-muscle-invasive bladder cancer (NMIBC).Methods This retrospective study evaluated 147 consecutive patients who underwent contrast-enhanced CT and surgery for bladder cancer. Using corticomedullary-to-portal venous phase images, two independent readers analyzed bladder muscle invasion, tumor stalk, and tumor size, respectively. Three-point scale (i.e., from 0 to 2) was applied for assessing the suspicion degree of muscle invasion or tumor stalk. A multivariate prediction model using the CT parameters for achieving high positive predictive value (PPV) for NMIBC was investigated. The PPVs from raw data or 1000 bootstrap resampling and inter-reader agreement using Gwet's AC1 were analyzed, respectively.Results Proportion of patients with NMIBC was 81.0% (119/147). The CT criteria of the prediction model were as follows: (a) muscle invasion score < 2; (b) tumor stalk score > 0; and (c) tumor size < 3 cm. From the raw data, PPV of the model for NMIBC was 92.7% (51/55; 95% confidence interval [CI] 82.4-98.0) in reader 1 and 93.3% (42/45; 95% CI 81.7-98.6) in reader 2. From the bootstrap data, PPV was 92.8% (95% CI 85.2-98.3) in reader 1 and 93.4% (95% CI 84.9-99.9) in reader 2. The model's AC1 was 0.753 (95% CI 0.647-0.859).Conclusion The current CT-derived prediction model demonstrated high PPV for identifying patients with NMIBC. Depending on CT findings, approximately 30% of patients with bladder cancer may have a low need for additional MRI for interpreting vesical imaging-reporting and data system.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 50 条
  • [41] Mutational landscape of non-muscle-invasive bladder cancer
    Hurst, Carolyn D.
    Knowles, Margaret A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (07) : 295 - 303
  • [42] Intravesical chemotherapy in non-muscle-invasive bladder cancer
    Porten, Sima P.
    Leapman, Michael S.
    Greene, Kirsten L.
    INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 297 - 303
  • [43] Current management of non-muscle-invasive bladder cancer
    Rodriguez Faba, O.
    Gaya, J. M.
    Lopez, J. M.
    Capell, M.
    De Gracia-Nieto, A. E.
    Gomez Correa, E.
    Breda, A.
    Palou, J.
    MINERVA MEDICA, 2013, 104 (03) : 273 - 286
  • [44] New therapies for non-muscle-invasive bladder cancer
    Chiong, Edmund
    Esuvaranathan, Kesavan
    WORLD JOURNAL OF UROLOGY, 2010, 28 (01) : 71 - 78
  • [45] Guideline of guidelines: non-muscle-invasive bladder cancer
    Woldu, Solomon L.
    Bagrodia, Aditya
    Lotan, Yair
    BJU INTERNATIONAL, 2017, 119 (03) : 371 - 380
  • [46] Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
    Russell, B.
    Leidberg, F.
    Hagberg, O.
    Ullen, A.
    Soderkvist, K.
    Strock, V.
    Aljabery, F.
    Gardmark, T.
    Jerlstrom, T.
    Sherif, A.
    Holmberg, L.
    Bryan, R. T.
    Enting, D.
    Van Hemelrijck, M.
    EUROPEAN UROLOGY, 2021, 79 : S1014 - S1015
  • [47] Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer
    Chamie, Karim
    Ballon-Landa, Eric
    Daskivich, Timothy J.
    Bassett, Jeffrey C.
    Lai, Julie
    Hanley, Jan M.
    Konety, Badrinath R.
    Litwin, Mark S.
    Saigal, Christopher S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 20.e9 - 20.e17
  • [48] Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer
    Semeniuk-Wojtas, Aleksandra
    Lubas, Arkadiusz
    Cierniak, Szczepan
    Brzoskowska, Urszula
    Syrylo, Tomasz
    Zielinski, Henryk
    Stec, Rafal
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (08) : 2099 - 2108
  • [49] Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer
    Aleksandra Semeniuk-Wojtaś
    Arkadiusz Lubas
    Szczepan Cierniak
    Urszula Brzóskowska
    Tomasz Syryło
    Henryk Zieliński
    Rafał Stec
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2099 - 2108
  • [50] Predictors of Outcome of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
    Youssef, Ramy F.
    Lotan, Yair
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 369 - 381